Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of an anti-IL6 receptor nanobody in rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Long Term Safety Extension Study (CHS-0214-05) [Phase 3]
Phase 3 long-term safety extension study for a therapy in rheumatoid arthritis and plaque psoriasis has completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update evaluating therapeutic drug monitoring of tocilizumab in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial comparing GP2017 with Humira in rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Masitinib in Refractory Active Rheumatoid Arthritis [Phase 2, Phase 3]
Clinical trial update for masitinib in refractory active rheumatoid arthritis shows termination after Phase 2/3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for masitinib in combination with methotrexate in active rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Niclosamide With Etanercept in Rheumatoid Arthritis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating niclosamide with etanercept for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® [Phase 4]
Phase 4 clinical trial evaluating how different antirheumatic treatments affect antibody response to vaccination with Prevenar in rheumatoid…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating oral AB1010 in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effect of Some Drugs on Rheumatoid Arithritis Activity [Phase 3]
Phase 3 clinical trial update evaluating the effect of some drugs on rheumatoid arthritis activity.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Statins and ARBs on Rheumatoid Activity [Phase 3]
A Phase 3 clinical trial is investigating the effects of statins and ARBs on rheumatoid arthritis activity and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. [Phase 4]
A Phase 4 clinical trial assessing the effectiveness of different early rheumatoid arthritis treatment strategies in real-world practice; re…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent [Phase 3]
Phase 3 trial evaluating tocilizumab (RoActemra/Actemra) as monotherapy or with non-biologic DMARDs in rheumatoid arthritis patients with in…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy [Phase 2]
Phase 2 clinical trial update for rheumatoid arthritis patients on methotrexate with inadequate response to TNF inhibitor therapy; results p…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial update assessing long-term safety and efficacy of BI 695501 in rheumatoid arthritis completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions [NA]
Clinical trial update comparing Augment Injectable Bone Graft to autologous bone graft for hindfoot fusions; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate [Phase 2]
Phase 2 clinical trial evaluating Pf-06651600 for rheumatoid arthritis with inadequate response to methotrexate has completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
Clinical trial update on etanercept focusing on remission in real-life practice for rheumatoid arthritis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
A completed clinical trial assessing the safety and efficacy of Etanercept (Enbrel) in patients with moderately active rheumatoid arthritis …
-
FDA approval · 2018-11-30FDA Approved: ETODOLAC — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's etodolac as a generic (ANDA 209888) for relief of signs and symptoms of osteoarthritis and rheumatoid a…
-
FDA approval · 2018-11-29FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., confirming regulatory clearance for an updated product-rel…
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab [Phase 4]
Phase 4 trial exploring musculoskeletal ultrasound to predict early dose titration of tocilizumab in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 mechanistic study of GSK3196165 plus methotrexate in active rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. [Phase 2]
Phase 2 trial updating on enalapril maleate for arterial stiffness in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial updates the use of subcutaneous tocilizumab as monotherapy or with non-biologic DMARDs in rheumatoid arthritis; resul…